Market Capitalization (Millions $) |
4,566 |
Shares
Outstanding (Millions) |
256 |
Employees |
9,300 |
Revenues (TTM) (Millions $) |
6,263 |
Net Income (TTM) (Millions $) |
1,023 |
Cash Flow (TTM) (Millions $) |
-13 |
Capital Exp. (TTM) (Millions $) |
253 |
Organon And Co
Organon and Co is a pharmaceutical company that was founded nearly a century and a half ago in the Netherlands. It has since grown into a global biopharmaceutical company that specializes in developing and manufacturing innovative medicines to improve patients' lives.
The company's name, Organon, refers to the Greek word "organon," which means "tool" or "instrument." This reflects Organon's mission to create tools and solutions to help physicians and healthcare providers feel confident in their treatment decisions.
Organon and Co's focus is on three main areas: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on developing and providing solutions for women's health and wellness, including contraception, infertility, and menopause treatments. The Biosimilars division aims to provide access to high-quality, affordable biosimilars, helping to increase patient access to life-saving biologic medicines. The Established Brands division focuses on providing innovative solutions to improve the health and well-being of patients, including treatments for cardiovascular disease, migraine, and schizophrenia.
Organon and Co is committed to advancing science and research to better understand and meet patients' needs. They invest heavily in research and development, focusing on developing innovative medicines and treatments using state-of-the-art technologies.
In addition to its focus on innovative research and development, Organon and Co is committed to social responsibility and sustainability. They have created programs and initiatives to promote health and wellness in underserved communities, reduce their environmental impact, and improve patient access to medicines.
Overall, Organon and Co's mission is to improve patients' lives by providing innovative solutions and treatments that address pressing medical needs. They are committed to advancing science and research, promoting social responsibility, and ensuring patient access to life-saving medicines.
Company Address: 30 Hudson Street, Floor 33 Jersey City 7302 NJ
Company Phone Number: 430-6900 Stock Exchange / Ticker: NYSE OGN
|